Companies · Other Health Care

Firm Of John Dickinson Schneider Inc

LIBERTYVILLE · Other Health Care

Diligence memoA one-page analyst read on Firm Of John Dickinson Schneider Inc — recommendation, valuation, rhythm, risks.
$34.2M
Total raised · real
10
Rounds
2.0×
Latest step-up
Top 12%
Sector rank · raised
Series B
Latest stage · inferred · Fri Jun 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Firm Of John Dickinson Schneider Inc looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.95× the median modeled value of Series B Other Health Care companies in 2022–2024 (91 peers) — value vs value, same stage and era.
  • Within the normal band (95% of peer median) for its niche.
At-risk
  • Last raise 3.0 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Firm Of John Dickinson Schneider Inc is one of 5377 Other Health Care companies tracked from LIBERTYVILLE. By capital raised it ranks in the upper tier (ahead of 89% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
279
Investors (latest)
2023-06-30
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2009-08-01 Raised $303K (real) Modeled valuation $9.3M (est)Pre-Seed2009Pre-Seed · 2009-08-01 Raised $303K (real) Modeled valuation $9.3M (est)Pre-Seed2009Pre-Seed · 2011-08-08 Raised $209K (real) Modeled valuation $6.4M (est)Pre-Seed2011Pre-Seed · 2013-07-01 Raised $600K (real) Modeled valuation $18M (est)Pre-Seed2013Seed · 2014-06-30 Raised $1.6M (real) Modeled valuation $39M (est)Seed2014Seed · 2015-06-30 Raised $2.6M (real) Modeled valuation $65M (est)Seed2015Seed · 2016-06-30 Raised $1.0M (real) Modeled valuation $25M (est)Seed2016Seed · 2017-06-30 Raised $2.1M (real) Modeled valuation $53M (est)Seed2017Seed · 2018-06-30 Raised $1.2M (real) Modeled valuation $30M (est)Seed2018Series A · 2022-06-30 Raised $8.3M (real) Modeled valuation $82M (est)Series A2022Series B · 2023-06-30 Raised $16M (real) Modeled valuation $145M (est)Series B2023Cumulative $35M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$303K · 2009
Pre-Seed extension$303K · 2009
Pre-Seed extension$209K · 2011
Pre-Seed extension$600K · 2013
Seed$1.6M · 2014
Seed extension$2.6M · 2015
Seed extension$1.0M · 2016
Seed extension$2.1M · 2017
Seed extension$1.2M · 2018
Series A$8.3M · 2022
Series B$16.3M · 2023

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$144.8M
Base estimate est.
$38.3M
Conservative case
$314.1M
Upside case
$90.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $9.3M · 2009-08-012009Pre-Seed · modeled $9.3M · 2009-08-01Pre-Seed · modeled $6.4M · 2011-08-08Pre-Seed · modeled $18.5M · 2013-07-01Seed · modeled $39.2M · 2014-06-30Seed · modeled $65.0M · 2015-06-30Seed · modeled $24.9M · 2016-06-30Seed · modeled $52.8M · 2017-06-30Seed · modeled $30.1M · 2018-06-30Series A · modeled $81.6M · 2022-06-30Series B · modeled $144.8M · 2023-06-302023
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
3.0 yr
Elapsed time used
3.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
17 mo
Avg between rounds
$2.5M/yr
Capital velocity
16.9 yr
On record since
2009
First round
11
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 14× above median
This company$34.2M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.9× of median
This company$16.3M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 6.6× above median
This company$144.8M
Sector median$22.1M

Raised more than 89% of sector peers (real $). Modeled value above 85% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #50 of 91.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Code Biotherapeutics, Inc. · Series B Raised $47.5M · modeled $465.8M (est)Candesant Biomedical, Inc. · Series B Raised $44.5M · modeled $455.3M (est)Artis Holdings, LLC · Series B Raised $40.0M · modeled $383.5M (est)GIO Blood Ltd · Series B Raised $27.3M · modeled $375.5M (est)Clarapath, Inc. · Series B Raised $40.2M · modeled $348.4M (est)Diality Inc · Series B Raised $42.9M · modeled $337.7M (est)VA Pro 7 SNF Operations Holdings LLC · Series B Raised $32.0M · modeled $333.3M (est)VivoSense, Inc. · Series B Raised $27.0M · modeled $332.6M (est)Tidal Wave GPO, LLC · Series B Raised $34.8M · modeled $324.6M (est)Peachy Corp. · Series B Raised $25.1M · modeled $309.9M (est)Smile Source Holdings, L.P. · Series B Raised $32.2M · modeled $309.0M (est)ASC San Rafael LLC · Series B Raised $28.3M · modeled $295.1M (est)Firm Of John Dickinson Schneider Inc (this company) Raised $34.2M · modeled $144.8M (est)Firm Of John Dickinson Schneider Inc
CompanyStageRaised · realValue · estvs peer med.
Code Biotherapeutics, Inc.Series B$47.5M$465.8M3.06×
Candesant Biomedical, Inc.Series B$44.5M$455.3M2.99×
Artis Holdings, LLCSeries B$40.0M$383.5M2.52×
GIO Blood LtdSeries B$27.3M$375.5M2.47×
Clarapath, Inc.Series B$40.2M$348.4M2.29×
Diality IncSeries B$42.9M$337.7M2.22×
VA Pro 7 SNF Operations Holdings LLCSeries B$32.0M$333.3M2.19×
VivoSense, Inc.Series B$27.0M$332.6M2.19×
Tidal Wave GPO, LLCSeries B$34.8M$324.6M2.13×
Peachy Corp.Series B$25.1M$309.9M2.04×
Smile Source Holdings, L.P.Series B$32.2M$309.0M2.03×
ASC San Rafael LLCSeries B$28.3M$295.1M1.94×
Firm Of John Dickinson Schneider Inc this companySeries B$34.2M$144.8M0.95×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$303K2009-08-01$1.7M$9.3M85%
Pre-Seed$303K2009-08-01$1.7M$9.3M85%
Pre-Seed$209K2011-08-08$1.2M$6.4M85%
Pre-Seed$600K2013-07-01$3.3M$18.5M85%
Seed$1.6M2014-06-30$7.9M$39.2M85%
Seed$2.6M2015-06-30$13.1M$65.0M85%
Seed$1.0M2016-06-30$5.0M$24.9M85%
Seed$2.1M2017-06-30$10.7M$52.8M90%
Seed$1.2M2018-06-30$6.1M$30.1M90%
Series A$8.3M2022-06-30$37.6M$81.6M90%
Series B$16.3M2023-06-30$90.5M$144.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$303K2009-08-01
    • First recorded raise — entered as Pre-Seed.
    • 9 investors on this round.
  2. Pre-Seed$303K2009-08-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 9 investors on this round.
  3. Pre-Seed$209K2011-08-08
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  4. Pre-Seed$600K2013-07-01
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 2.9× larger than the prior — scaling up.
  5. Seed$1.6M2014-06-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.6× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 113 investors on this round.
  6. Seed$2.6M2015-06-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • 75 investors on this round.
  7. Seed$1.0M2016-06-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.6× smaller than the prior — bridge or down round.
    • 76 investors on this round.
  8. Seed$2.1M2017-06-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • 90 investors on this round.
  9. Seed$1.2M2018-06-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 178 investors on this round.
  10. Series A$8.3M2022-06-30
    • Raised again after 48 mo — slower than the ~14 mo sector norm.
    • Round 6.8× larger than the prior — scaling up.
    • 236 investors on this round.
  11. Series B$16.3M2023-06-30
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
    • 279 investors on this round.
Intelligence
2024 ~Q4
Modeled next raise · ~17mo cadence
$32.1M
Modeled next size est.range $20.9M$51.4M
2.0×
Last step-up
$2.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Alan F. Herbert2009-08
Amanda L. Brunner2023-06
Carlyn D. Solomon2016-06
Dian J. Thielitz2009-08
Donna J. Matson2011-08
Elizabeth P. Lindner2011-08
Elizabeth R. Lindner2009-08
James D. Adducci2018-06
James W. Humphries2022-06
Jerome A. Saxon2018-06
Jerome J. Saxon2009-08
Kenneth A. Straup2015-06
Lise M. Heroux2022-06
Mark G Kalifa2022-06
Melvin R. Haught2009-08
Richard J. Zwirner2011-08
Richard T. Zwirner2009-08
Robert C. Keeley2013-07
Scott A. Holloway2022-06
Sharon M. Brady2017-06
Sheila R. Johnson2009-08
Stephen P. Carter2009-08
Stuart P. Edgley2023-06
Susan C. Nutson2023-06
Registry & provenance

Firm Of John Dickinson Schneider Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
798320
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
General Fluidics CorpOther Health CareSeries B$34.6M$119.4Msame sector · same stage
January, Inc.Other Health CareSeries B$33.5M$152.2Msame sector · same stage
GHR Acquisition, LLCOther Health CareSeries B$35.3M$123.9Msame sector · same stage
HomeThrive, Inc.Other Health CareSeries B$35.3M$131.9Msame sector · same stage
ZT Sapphire Fund I, L.P.Other Health CareSeries B$33.0M$117.2Msame sector · same stage
Getlabs, Inc.Other Health CareSeries B$35.7M$161.8Msame sector · same stage
STX Healthcare Management Services, Inc.Other Health CareSeries B$35.7M$128.2Msame sector · same stage
Myra Vision, Inc.Other Health CareSeries B$36.0M$108.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Mitesco, Inc.Other Health CareSeries A$395K83%
Pregimmune CorpOther Health CarePre-Seed$1.5M81%
Ndal Mfg, Inc.Other Health CareSeed$20.2M81%
True North Contract Research, Inc.Other Health CareSeed$14.5M81%
New MMI Holdings, Inc.Other Health CareSeries C$1.8B81%
NorCal Holding Company, Inc.Other Health CareSeries A$100.9M81%
Nexus M.D., LLCOther Health CarePre-Seed$12.3M81%
MorphImmune Inc.Other Health CareSeries B$139.7M81%
Frequently asked
How much funding has Firm Of John Dickinson Schneider Inc raised?
Firm Of John Dickinson Schneider Inc has raised approximately $34.2M in disclosed capital across 10 recorded financing rounds, aggregated from public filings.
What is Firm Of John Dickinson Schneider Inc's estimated valuation?
Provath's modeled valuation for Firm Of John Dickinson Schneider Inc is approximately $144.8M (modeled range $38.3M–$314.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Firm Of John Dickinson Schneider Inc at?
Firm Of John Dickinson Schneider Inc's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Jun 30.
What does Firm Of John Dickinson Schneider Inc do and where is it based?
Firm Of John Dickinson Schneider Inc operates in the Other Health Care sector, based in LIBERTYVILLE.
Explore related

See where Firm Of John Dickinson Schneider Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Firm Of John Dickinson Schneider Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.